Podcasts about cgms

Biohacking and longevity are everywhere—CGMs, peptides, cold plunges, sauna protocols, and expensive testing—all chasing the same outcome: live longer and function better.But here's what most people miss: the strongest longevity principles aren't new. They're ancient. They're biblical. And modern science keeps “discovering” what God already designed. In this episode of The OWN IT Show, Justin breaks down 5 biblical habits for longevity—and the science behind why they work—through one core lens: health is worship, not performance.You'll learn:✅ Sabbath (Recovery): why your body needs a real stop—and why God called it holy ✅ Fasting (Cellular repair): what autophagy is, and why fasting is formation—not a flex ✅ Community (Belonging): why covenant community builds resilience (and why “networking” isn't the same)✅ Movement (Strength + stamina): why discipline is stewardship for the long haul ✅ Food (Whole ingredients): why “grandma food” still wins—simple, recognizable, minimally processedThe deeper point: longevity without purpose becomes “optimization without telos”—better numbers, but an unchanged life.If this hit you, share it with someone chasing health—but missing the why. And remember: we were given the right answers for free… so take care of the temple. ============================================================================Our Sponsor:The Rise of the Health Haven Documentary — Watch the full story of how Justin and Alyse transformed their backyard into a purpose-built wellness sanctuary. From the vision to the build to the partners who made it possible, The Rise of the Health Haven is a front-row look at what a life designed around health, faith, and intention actually looks like in practice: https://bit.ly/4v6lYE8RTA Outdoor Living: RTA Outdoor Living helps families create safe, personalized outdoor kitchens built to last. Through expert guidance, premium American-made materials, and a simplified one-stop process, we help homeowners transform their backyards into meaningful spaces for connection, cooking, and lasting memories. https://rtaoutdoorliving.com/Support the show

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.In this episode, Coach Ken and Graham tackle one of the most fascinating and controversial questions in the diabetes world:What will happen first—a cure for Type 1 diabetes or a way to prevent it altogether?The conversation begins with a discussion around continuous glucose monitors, the barriers to bringing new diabetes technology to market, and why FDA approval plays such a significant role in innovation and accessibility.From there, Ken and Graham zoom out to examine diabetes on a global scale. They explore the challenges people with diabetes face in developing countries, the realities of insulin access, and whether advanced technology like CGMs should be prioritized when many people still struggle to obtain life-saving insulin.The discussion then shifts into the future of Type 1 diabetes research, including Teplizumab (Tzield), immunotherapy, stem cell research, autoimmune triggers, and the ongoing debate between prevention and cure.Along the way, Ken shares his perspective on the role that lifestyle factors—including stress, sleep, nutrition, exercise, and overall health—may play in autoimmune conditions, while Graham challenges the conversation by exploring whether vaccines, immunotherapy, or preventative treatments could eventually become the standard approach.This episode is an honest discussion about innovation, skepticism, hope, and the future of diabetes care.

Can Direct Primary Care really pay off for a physician family carrying student loan debt and no employer match? In this episode of the My DPC Story podcast, host Dr. Maryal Concepcion talks with Dr. Manuel Vogt of Texas DPC about the real financial tools behind building a thriving practice.From a billboard at a railroad crossing to a 220-patient pre-enrollment list on opening day, Dr. Vogt shares how he and his wife built two separate Direct Primary Care clinics in San Antonio while protecting each other's autonomy. The standout story: how they used federal and state historic preservation tax credits, ADA credits, and a solar carport credit to fund a clinic renovation, then sold the state credits for 93 cents on the dollar.In this episode you'll learn:How a physician couple runs two independent DPC practices as a familyUsing historic tax credits to fund a clinic renovationSubleasing clinic space to cover your entire overheadMarketing to employers through a multi-clinic DPC umbrellaA workaround for Texas dispensing laws and discounted wholesale labsBetter diabetes care with CGMs and same-day textingFinding the panel size (around 500) that supports a daily 5K and school pickupsA pricing strategy that raises rates without losing patientsAdvocacy priorities: in-office dispensing and FSA eligibilityWhether you are a resident exploring Direct Primary Care or an established DPC owner planning expansion, this conversation is full of practical, money-saving ideas.

Blutzucker ist gerade überall Thema. Glukose-Sensoren, Blutzucker-Achterbahn, Insulinresistenz, Heißhunger, Energie-Crashs. Gleichzeitig herrscht total viel Verwirrung. Muss wirklich jeder seinen Blutzucker tracken? Ist jeder Anstieg nach dem Essen schlecht? Und warum fühlen sich manche Menschen nach einer Mahlzeit fit – während andere direkt wieder Lust auf Süßes bekommen? Genau darüber sprechen ich in dieser Episode mit Ernährungswissenschaftlerin Marie-Luise Huber. Du erfährst, was im Körper nach dem Essen tatsächlich passiert, wann Blutzucker problematisch werden kann und welche Rolle Ernährung, Schlaf, Stress, Zyklus und Bewegung dabei spielen.

In this episode, Meg Bomley shares her T1D journey from being diagnosed at 18 years old and spending eight years on MDI without a CGM, to becoming someone who feels deeply empowered in her body and her diabetes.Meg first came on the podcast in 2022 after graduating from Risely coaching. At the time, she had just come out of a season of constant lows, burnout, and feeling completely overwhelmed after switching to a pump without the support she needed.Today, she's back as a nationally board certified health coach, and 35 weeks pregnant with type 1 diabetes, one of Risely's top coaches.The majority of this conversation is the reality of navigating pregnancy with T1D: the nausea, insulin resistance, fear of highs, changing carb ratios, and learning to trust yourself in this season.WHAT WE COVER:Why Meg resisted pumps and CGMs for nearly 8 years after diagnosisThe “biggest disaster ever” that happened when she first switched to a pumpWhat finally helped her stop feeling resistant, overwhelmed, and burnt out with diabetesHow coaching helped her uncover mindset blocks that had nothing to do with insulin or carb countingThe first sign Meg noticed that told her her insulin resistance was changing after getting pregnantHow she managed nausea, vomiting, insulin on board, and eating mostly carbs during pregnancyThe difference between taking 5 units for oatmeal pre-pregnancy vs. 16 units during pregnancyWhat it's actually like mentally to watch yourself take “large amounts of insulin” every dayWHAT'S NEXT:

What diabetes technology is actually helping people right now—and how do you figure out what fits best into your life?In this 100th episode of the TCOYD Podcast, Dr. E and Dr. P are joined by diabetes nurse practitioner and educator Rachael Sood, founder of The Diabetes Collective, to talk through the latest updates in diabetes technology and what they're seeing in real-world diabetes care.The conversation focuses on how much diabetes technology has changed over the past few years, from hybrid closed loop systems and CGMs to new developments in sensing and automation. Rather than focusing on one “best” device, the discussion centers around finding the right fit for each person's lifestyle, preferences, and goals.Dr. E, Dr. P, and Rachael also talk about where technology may be headed next, including dual glucose and ketone sensors, more compatibility between pumps and CGMs, and the possibility of systems that require less hands-on work from people living with diabetes. The takeaway is encouraging: there are more tools and options than ever before, and diabetes technology continues to move toward making daily management simpler, safer, and more flexible.Key Topics• Choosing the right insulin pump and CGM• Tubed vs. tubeless pump systems• How lifestyle and personal preference shape technology choices• The latest updates in automated insulin delivery systems• Dexcom G7 10-day vs. 15-day sensors• Abbott's dual glucose and ketone sensor technology• Medtronic's newest technology developments• Real-world conversations patients have about wearing devices• Continuous ketone monitoring and DKA prevention• The future of fully closed loop systems• Why compatibility between pumps and CGMs matters• Technology options for people with type 2 diabetes• Where diabetes technology may be headed next✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram:   / tcoydFacebook:   / tcoydStay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.In this episode, Ken and Graham dive into one of the biggest frustrations people living with Type 1 diabetes face: the gap between medical care and real-life diabetes management.The conversation starts with a powerful discussion around endocrinologists, insulin safety, and why most healthcare providers are forced to prioritize preventing dangerous lows over helping patients aggressively optimize blood sugars. Ken explains how fear of hypoglycemia, liability, and limitations within the healthcare system shape the guidance many people receive.From there, the episode evolves into a deep real-world conversation around:insulin pumps and automationdawn phenomenoninsulin resistance from stresslearning patterns and building “checklists”trusting Dexcom trend arrowsand how to actually troubleshoot blood sugar problems in real timeGraham also shares a brutally honest look into the mental frustration of waking up high from dawn phenomenon despite doing “everything right,” leading to a conversation many people with diabetes quietly relate to but rarely talk about openly.This episode blends education, emotional reality, and practical problem-solving into one of the most relatable diabetes conversations yet.

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.In this episode, Ken and Graham dive into one of the most overlooked parts of living with diabetes: the stories, beliefs, and identity patterns we create over time.What starts as a conversation about childhood experiences, sports, discipline, and self-worth evolves into a much deeper discussion about how people approach diabetes management—and why so many struggle with consistency, burnout, and decision-making.Ken opens up about growing up without a strong male role model, feeling like he had to figure everything out alone, and how those experiences shaped the way he approached school, sports, and eventually diabetes. The conversation connects these personal experiences directly back to Type 1 diabetes and the reality that most people naturally gravitate toward what feels easiest, most enjoyable, or least mentally exhausting.Ken and Graham also unpack:why people avoid pre-bolusing even when they know it helpsthe frustration with pumps and CGMs not being “perfect”how people pick and choose where they spend mental energyand why diabetes management has to fit into real life—not replace itThe episode finishes with a powerful hypothetical conversation:What if Ken had been diagnosed with diabetes in high school instead of adulthood?That leads into a raw and honest discussion around denial, immaturity, identity, athletics, mental health, and how different life experiences shape the way people respond to diabetes.This episode is deeply personal, reflective, and relatable for anyone who has ever struggled to balance diabetes with actually wanting to live life.

It's In The News, where we bring you the top diabetes stories and headlines happening now. Top stories this week: Dexcom shares details of its next generation CGM, T1D and GLP-1 studies, weight loss management on GLP-1 medications updates, all-in-one CGM and pump, and more! Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcript: XX Dexcom announces some features of it's next generation CGM – the G8. We've been talking about this with CEO Jake Leach for a while now – it will be a 50% smaller with what they're calling advanced sensing capabilities. According to Leach, G8 will adapt to the physiologic variability of each user. It has additional technology built in, based on a new silicon chip design and algorithm. 15 day wear is now the baseline for all Dexcom sensors moving forward. At launch the G8 will only measure glucose but the plan is for a multi-analyte version to follow. That would measure ketones and potassium. Ketones we know – but potassium is very important for people with kidney and possible for people taking some diabetes meds. It's an interesting space to watch.. btw, analyte is just a medical word for the specific thing you're measuring – the target of the test you're running. we're going to hear that word a lot I think..   Looks like an FDA submission for the G8 next year.. with an outside the US launch the following year. https://www.drugdeliverybusiness.com/dexcom-unveils-next-gen-g8-cgm/ XX Glucotrack has submitted its implantable continuous blood glucose monitor (CBGM) for FDA IDE, that's investigational device exemption and would enable the company to initiate a U.S. clinical study for the fully implantable technology. Rutherford, New Jersey-based Glucotrack's device features no on-body external component. The company aims to offer it for three years of continuous, accurate blood glucose monitoring for a more convenient, less intrusive solution. Unlike traditional CGMs that measure glucose in interstitial fluid, the CBGM measures glucose levels directly from the blood. The implant goes five centimeters within the subclavian vein. Glucotrack's active implantable device has a small battery and some electronics that go just under the skin in the pectoral region. The location of the implant is not in a major vessel, but the implant can measure real-time glucose levels as pulsatile blood flows over the tip of the sensor. https://www.drugdeliverybusiness.com/glucotrack-submits-long-term-implantable-cbgm-fda-ide/ XX PharmaSens today announced the publication of data from the first clinical study evaluating its all-in-one insulin patch pump offering. The all-in-one pump pairs the Niaa Essential insulin patch pump with the SynerG continuous glucose monitor (CGM) sensor developed by Pacific Diabetes Technologies. However, this system would be one device that features both the pump and CGM technology.   PharmaSens and SiBionics also have a collaboration aimed at developing the all-in-one solution. They are jointly developing the next-generation Niia insulin patch pump with a SiBionics CGM. PharmaSens expects a second feasibility study in the second quarter to evaluate the next-generation pump with SiBionics' CGM.   PharmaSens says the clinical feasibility study of Niia demonstrated for the first time ever that the combined offering is, in fact, feasible. It believes its device addresses the need for alternatives to multi-device diabetes management. systems.   Aggregated MARD for the investigational device came in at 11.6%. A MARD target of less than 10% is considered ideal for CGM devices, but PharmaSens said that, in the context of the early feasibility study, the results were encouraging and provide evidence supporting the development of an all-in-one system. https://www.drugdeliverybusiness.com/pharmasens-efs-insulin-patch-pump-cgm/ XX   XX ViCentra launches the newest version of the Kaleido pump system in Europe. This is that small colorful pump, with Diabeloops algorithm and the Dexcom G7. It'll be in Germany and the Netherlands later this summer. https://hellokaleido.com/vicentra-announces-commercial-launch-of-new-smartphone-controlled-kaleido-automated-insulin-delivery-patch-pump-system/--   XX Diabeloop just got CE Mark approval for DBLG2 integrations – it's latest AID platform the company has kicked off the gradual European launch of the technology. It currently offers DBLG2 as a smartphone application on Android, with iOS integration coming soon. As you just heard, it's integrated with kaleido and the company says it plans to make additional configuration for DBLG2 with alternative pumps "available soon." Running on a user's smartphone, DBLG2 works as a self-learning algorithm. It continuously analyzes glucose data, calculates insulin needs in real time and automatically adjusts delivery. https://www.drugdeliverybusiness.com/diabeloop-fda-next-gen-algorithm-g7/   XX Among adults with type 1 diabetes (T1D), the initiation of GLP-1-based therapy was associated with a lower risk for all-cause death, several cardiovascular outcomes, all-cause hospitalisations, and hypoglycaemia, without a higher risk for diabetic ketoacidosis.   METHODOLOGY: Researchers in Greece conducted a retrospective cohort study utilising real-world data from a global health research network to evaluate the association between GLP-1-based therapy and cardiovascular and renal outcomes in adults with T1D. A total of 4088 patients receiving GLP-1-based therapies (median age, 43 years; 34.3% men) were propensity score matched with an equal number of patients not receiving the treatment. The risk for hypoglycaemia was lower with GLP-1-based therapy (hazard ratio, 0.72; P = .021); however, the risk for diabetic ketoacidosis did not differ significantly between the two groups. https://www.medscape.com/viewarticle/glp-1-drugs-tied-cardiovascular-benefits-t1d-2026a1000fbx   XX Eli Lilly and Company (NYSE: LLY) today announced detailed results from two late-phase trials showing that people with obesity maintained their weight loss long term with either Foundayo or lower-dose Zepbound after switching from higher doses of injectable incretin therapy. The findings from SURMOUNT-MAINTAIN and ATTAIN-MAINTAIN, were presented at the 33rd European Congress on Obesity (ECO) and published in The Lancet and Nature Medicine, respectively.   "Weight regain remains one of the biggest challenges in obesity care, and is often the result of treatment interruptions that cause biology to work against patients, undoing the progress they've made," said Louis J. Aronne, M.D., FACP, DABOM, founder and Chair Emeritus of the American Board of Obesity Medicine, former president of The Obesity Society, Fellow of the American College of Physicians, world-renowned obesity specialist and Lilly consultant. "These medicines can be used for long-term maintenance today, and results from SURMOUNT-MAINTAIN and ATTAIN-MAINTAIN provide additional evidence of their potential when switching from higher doses of injectable incretin therapy." https://investor.lilly.com/news-releases/news-release-details/lillys-foundayo-and-lower-dose-zepbound-helped-people-maintain XX Scientists in Sweden have developed a more reliable way to create insulin-producing cells from human stem cells. These lab-grown cells not only respond strongly to glucose but were also able to restore blood sugar control when transplanted into diabetic mice. When transplanted into diabetic mice, the cells gradually restored the animals' ability to regulate blood sugar. Long way to go, as we say with most of these mice studies. https://www.sciencedaily.com/releases/2026/05/260505234620.htm XX Interesting look at how the body controls sugar storage – apparently this finding challenges long-standing biology concepts and could open new directions for disease treatment. Published in Nature, the study describes a potential method for directly reducing glycogen, the stored form of sugar in the body. These scientists discovered that glycogen can be directly regulated by ubiquitin, a protein best known for marking damaged proteins for recycling or removal. The study is the first to show that ubiquitin can regulate glycogen in humans, overturning more than 50 years of scientific understanding. Excess glycogen is also associated with more common health problems, including diabetes, obesity, liver disease, and heart disease.       https://scitechdaily.com/scientists-just-rewrote-biology-hidden-mechanism-could-transform-diabetes-treatment/ XX A new Oklahoma law will give parents the option to have their children screened for Type 1 Diabetes.   The measure passed with overwhelming bipartisan support in the Legislature and takes effect Nov 1. Oklahoma consistently ranks among the states with the highest rates of diabetes and diabetes-related deaths. The law gives parents access to antibody testing that can detect risk years before symptoms develop, helping families take preventive action and avoid emergency room visits. https://journalrecord.com/2026/05/11/oklahoma-law-expands-access-type-1-diabetes-screening/ XX More to come including a new study trying to figure out why some people are more likely to develop diabetes, a look at cannabis and preventing metabolic disorders, and XX   A National Institutes of Health (NIH)-funded study has identified key differences in human pancreatic islet cells that may help explain why some people are more likely to develop diabetes. Researchers found that the mix of hormone-producing cells in the pancreas varies widely from person to person, and that variation plays a central role in how the body regulates blood sugar. The study involved a deep dive into islet cell function that is linked to donor traits associated with observable characteristics, or phenotype, such as sex, race and ethnicity, as well as genetic information, or genotype, including predicted ancestry and genetic risk for both type 1 and type 2 diabetes. The findings highlight that islet cell composition, rather than the physical size and shape of islets, is a key factor in regulating hormone release. The team found that the makeup of pancreatic islets plays a major role in how effectively they release insulin and glucagon — key hormones that regulate blood glucose. Islets with a higher proportion of insulin-producing beta cells showed stronger insulin secretion in response to various stimuli, while higher levels of alpha and delta cells were generally linked to reduced insulin output. In addition, the researchers found that islet hormone secretion is affected by donor traits, such as sex, race and ethnicity and their genetic makeup, including ancestry predicted from genetic testing and genetic risk for type 2 diabetes. Combined, the findings of the study have significant implications for understanding the factors that may predispose people to diabetes. "This study is the tip of the iceberg," said Dr. Evans-Molina. "We hope this dataset becomes useful to the entire diabetes research community and that researchers use it to answer questions about the genotype-phenotype correlation within these data."   https://www.nih.gov/news-events/news-releases/nih-funded-study-maps-human-pancreatic-islet-cells-offering-new-clues-diabetes-risk XX XX XX Research published recently in JAMA Network Open offers illuminating evidence suggesting there is a positive association between GLP-1 agonists—drugs commonly used to treat obesity and diabetes—and better outcomes among breast cancer patients.   "This study suggests that GLP-1 drugs may offer protective benefits potentially improving survival and recurrence risk in some female patients with breast cancer – whether this is related to weight control, improve cardiovascular health or other mechanisms remains to be studied," said study senior author Bernard F. Fuemmeler, Ph.D., MPH, associate director for population sciences and the Gordon D. Ginder, M.D., Chair in Cancer Research at VCU Massey Comprehensive Cancer Center.   Breast cancer patients who are also obese or have type 2 diabetes experience more aggressive cancer growth and worse outcomes. Prior studies have shown that weight loss treatment and surgery following a breast cancer diagnosis are associated with improved heart health and increased survival.   What are GLP-1 drugs? Glucagon-like peptide-1 receptor agonists (GLP-1 RAs). Approved to treat type 2 diabetes in 2005 and weight management in 2021. Impacts on breast cancer survival and recurrence are still unclear. Since 2020, the use of these drugs has increased dramatically, where approximately 12% of Americans have used GLP-1s for weight loss, according to a RAND report.   The research findings Through a retrospective cohort study examining the electronic health records of more than 840,000 breast cancer patients who were diagnosed between 2006 and 2023, the results suggest there is a potential link between GLP-1 RAs and improved outcomes among breast cancer patients who are also obese or have type 2 diabetes.   GLP-1 RA use was associated with an overall lower risk of death from any cause over a 10-year follow-up period among breast cancer patients. Additionally, breast cancer survivors who used GLP1-RAs for diabetes or obesity had a significantly lower risk of their cancer returning over 10 years following their initial treatment.   "Our findings align with emerging preclinical research and contribute to a growing body of literature related to GLP-1 RA use in oncology settings," said study lead author Kristina L. Tatum, PsyD, MS, of the VCU School of Public Health.   What's next? Further studies are needed to understand the biological mechanisms, if any, between GLP-1 RAs and breast cancer outcomes. The research team intends to further evaluate these correlations through randomized clinical trials.   "Our study underscores the potential of GLP-1 RAs as an adjunct strategy for improving cancer-related outcomes among patients with breast cancer, although clinical trials are needed to inform effective therapeutic approaches and clinical decision making," Fuemmeler said. https://www.oncology-central.com/could-glp-1-receptor-agonists-improve-outcomes-for-breast-cancer-patients-with-obesity-or-with-type-2-diabetes/ XX Researchers at UC Riverside gave cannabis to obese mice and found that not only did the rodents lose weight, but when given a concentrated cannabis oil, the mice also saw striking benefits in their metabolic function. DiPatrizio said his team studied the issue to better understand why cannabis users show significant reductions in weight and risk for diabetes compared with nonusers. "We would think that chronic cannabis users would be eating more and weigh more, but it's just the opposite," DiPatrizio said. Scientists are increasingly examining the possibility that cannabis compounds could fight obesity or metabolic disorders like diabetes. Cannabinoids interact with the body's endocannabinoid system, which partially controls nearly every aspect of our physiology, including metabolism and appetite. That creates the possibility that targeting this widespread system could unlock new therapies for these conditions. https://www.sfgate.com/cannabis/article/cannabis-weight-loss-california-study-22255328.php XX A new campaign launched by diaTribe and Genentech aims to empower and educate people about diabetes-related eye disease. Here's what you can do today to protect your eye health. To help address these barriers, diaTribe and Genentech partnered to launch All Eyes on DME, a new campaign that aims to spread awareness and educate people at-risk for or living with diabetes-related eye conditions like DME. Also partnering in the campaign is actor and comedian Damon Wayans, who wanted to share his journey (and, of course, a joke or two) with type 2 diabetes to open up the conversation about what is often a stigmatized or less talked about topic: eye health and diabetes.   One of these important conversations happened recently at the All Eyes on DME launch in New York City, where Wayans joined a panel of experts, advocates, and people living with DME to talk about diabetes-related eye disease and how to help prevent it. https://www.alleyesondme.com/dme-in-the-spotlight.html https://diatribe.org/diabetes-complications/all-eyes-dme-new-campaign-spotlights-eye-health-and-diabetes

Rafael Pepen was diagnosed with Type 1 diabetes at 17, right in the middle of rehearsing for his very first musical in the Dominican Republic. Without access to a CGM or carb counting education, he learned to manage largely on instinct. Years later, he moved to the US, pursued his dream of performing professionally, and eventually landed at Disney, where he now performs five high cardio shows a day.In this episode, Rafael sits down with Lauren to talk about what it actually looks like to manage T1D in a life that never slows down. He shares the months of burnout, panic attacks around lows, and constant roller coaster blood sugars that led him to seek coaching, and what shifted on the other side of that.WHAT WE COVER:What it was like to be diagnosed at 17 in the Dominican Republic with limited access to education, CGMs, or carb counting guidanceThe unique challenge of managing T1D across five high cardio shows a day and why it is a completely different beast from a traditional performance scheduleThe moment things started to unravel at Disney and what five months of daily lows, panic attacks, and burnout actually felt like from the insideWhat shifted when Rafael started working with a Risely coach and the tools that made the biggest difference for his day to day managementThe emotional side of T1D that most people never talk about, including what it felt like to cry during a low and the moment that started to changeWhat Rafael is still working toward and the one thing he wants most from his relationship with diabetes going forwardWHAT'S NEXT:

Cortisol is getting blamed for basically everything online, and we get why it's tempting: it gives a neat explanation for feeling tired, stressed, bloated, or “off.” But as a family medicine doctor and a nurse, we want to bring the conversation back to what cortisol actually does, what real testing looks like, and why most people don't need to treat normal life stress like a hormonal crisis.From there, we zoom out to other trendy health topics we keep seeing everywhere: gut health and the microbiome, pricey supplement stacks, and the promise that one test will finally explain your symptoms. We talk about the evidence and the limits, plus the unglamorous basics that move the needle for most people: fiber, plants, sleep, exercise, and cutting back on ultra-processed foods.We also dig into CGMs and “glucose spikes,” including what's normal (yes, exercise can raise glucose) and what actually signals risk, like blood sugar staying elevated after meals. Then we hit high-protein culture, why protein helps, why more isn't always better, and how longevity trends can distract from what matters most. Our bottom line: wellness marketing moves faster than science, so we aim for practical, evidence-based choices you can stick with.If you found this helpful, subscribe, share it with a friend who's stuck in health-trend overwhelm, and leave a review so more people can find the show.Send us a (voice ) message with this link, we would love to hear from you. Standard message rates may apply.Support the showProduction and Content: Edward Delesky, MD, DABOM & Nicole Aruffo, RNArtwork Rebrand and Avatars:Vantage Design Works (Vanessa Jones) Website: https://www.vantagedesignworks.com/Instagram: https://www.instagram.com/vantagedesignworks?igsh=aHRuOW93dmxuOG9m&utm_source=qrOriginal Artwork Concept: Olivia Pawlowski

Fasting, nutrient timing, chrono-nutrition, and continuous glucose monitoring are all topics that have generated substantial interest, but they are also areas where exaggerated claims can easily outpace the underlying evidence. In many cases, tentative hypotheses are presented as if they were already well-established conclusions, despite the fact that the research base is often more mixed and context-dependent than popular narratives imply. It is one thing for an idea to appear biologically coherent. It is another for that idea to translate into meaningful, reliable effects in real-world interventions. In this episode, Professor James Betts discusses how to think clearly about these topics, why common errors in interpretation can lead to overstated conclusions, and what is required to properly evaluate whether an observed effect reflects a true intervention effect rather than baseline differences, inappropriate comparisons, within-group changes, or mechanistic signals being mistaken for meaningful health outcomes. Timestamps: [04:24] Background into Prof. Betts' research [07:28] Evidence in fasting research over past 5-6 years [10:15] Hype vs evidence in intermittent fasting [16:44] Spotting spin in study conclusions [17:31] Common statistical red flags [24:45] Methods matter in fasting trials [31:10] Exercise nutrient timing [38:32] CGMs what they measure, misuse and patterns [53:59] Key ideas (premium-only)   Links: Go to episode page & resources (study links, bio, etc.) Join the Sigma newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course

What if your genes are not your destiny, but a set of clues your body has been giving you all along? In this episode, Dr. Taz sits down with Dr. Florence Comite, endocrinologist, clinician scientist, longevity expert, and author of Invincible: Defy Your Genetic Destiny to Live Better, Longer, to explore how biomarkers, genetics, hormones, sleep, metabolism, and family history shape the way we age.In this episode, Dr. Comite explains why longevity is not just about biohacking, supplements, peptides, or the latest wellness trend. Instead, she shares why true healthspan begins with understanding your own body, your own patterns, and your own family story. She explains how changes in blood sugar, fasting insulin, free testosterone, cholesterol risk ratio, sleep quality, muscle, and metabolism can reveal early signs of disease risk long before symptoms fully appear.Dr. Taz and Dr. Comite discuss why “normal” lab ranges are not always the same as optimal health, why some people begin showing signs of metabolic disease decades earlier than expected, and how family history can act as a powerful roadmap for prevention. They also explore how genetics, lifestyle, hormones, wearables, continuous glucose monitoring, sleep, movement, protein, and personalized medicine may help people change the trajectory of their future health.If you're listening to this and thinking, “I know something is off in my body, but I don't know where to start,” join the Circle here:

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.In this episode, Coach Ken and Graham open up a conversation that doesn't get talked about enough—intimacy and relationships while living with diabetes.From managing BS during intimate moments to navigating confidence, communication, and vulnerability, this episode highlights a side of diabetes that often gets overlooked.Ken and Graham break down the real-life challenges people face, including concerns about highs and lows, wearing devices like CGMs or pumps, and the mental load that can show up in relationships.The conversation expands into how diabetes can impact self-image, confidence, and connection, and why avoiding these conversations can create more stress over time.

We can measure more about our health than ever before. Wearables track everything from heart rhythms to glucose trends, and AI can now identify patterns clinicians might miss. But more data does not automatically mean better health outcomes.In this episode, cardiologist and digital health expert Dr. Ami Bhatt joins Mike Haney to explore why medicine still struggles with prevention, how continuous health data can help patients take more agency, and where AI may actually improve care—not by replacing doctors, but by helping clinicians navigate the right information at the right time.They discuss the promise and pitfalls of wearables, the challenge of turning constant streams of health information into useful action, and why the future of medicine may depend on what Dr. Bhatt calls “collaborative intelligence”: humans and AI working together to make better decisions earlier.About the guest: Dr. Ami Bhatt is the chief innovation officer (CIO) at the American College of Cardiology and the Chair of the FDA Digital Health Advisory Committee. She received her undergraduate degree at Harvard University and her Doctor of Medicine at Yale University School of Medicine, and was the Director of Outpatient Cardiology, TeleCardiology, and Adult Congenital Heart Disease at the Massachusetts General Hospital.Sign Up to Get Your Free Ultimate Guide to Glucose: ⁠⁠⁠⁠⁠⁠⁠https://levels.link/wnl⁠⁠⁠⁠⁠⁠

This week on The AGEIST Podcast, Dr. Florence Comite,  clinician-scientist, and author of Invincible: Defy Your Genetic Destiny to Live Better, Longer, explains why “normal” lab results can miss the early signals that shape long-term health. Learn how sugar, insulin, A1C, cholesterol patterns, HDL, and free testosterone can reveal metabolic changes before a conventional diagnosis appears. She makes the case for tools like CGMs, deeper family history, better sleep, strength training, and hormone awareness as practical ways to understand what is happening beneath the surface. The episode gives the audience a clear framework for asking better questions, acting earlier, and taking more precise ownership of the next decades of their health.Are you competing in the Super Age Games? Join us at the first longevity fitness competition on Nov 7, 2026. Visit games.superage.com to learn more.Special Thanks to Our SponsorsTimeline Nutrition: Our favorite supplement for cell support and mitochondrial function. Listeners can now get 20% off their first Timeline purchase by using the code “AGEIST” at checkout at TimelineNutrition.com/ageist.LMNT Electrolytes: Our #1 electrolyte brand for optimal hydration, and their new 12oz sparkling cans are officially for sale online! Get a free Sample Pack of LMNT's most popular drink mix flavors with any purchase by using our link here. Find your favorite LMNT flavor, or share with a friend.Key Moments“I want everyone to own their future health destiny.”“The first phrase that's completely wrong is you're in the normal range and everybody relaxes.”“Aging is not a disease, it's a gift.”Connect with Dr. ComiteWebsiteComiteMDInvincible: Defy Your Genetic Destiny to Live Better, LongerConnect with AGEISTNewsletterInstagramWebsiteLinkedInClick Here for the full interview transcript.Say hi to the AGEIST team!

Most high performers don't realize they're running at 70% until someone shows them what 100% feels like. Dr. Tracy Gapin did —, and it changed everything. He was a busy urological surgeon: overweight, stressed, and ironically receiving the same inadequate "normal" care he was giving his own patients. So he walked away from traditional medicine to build something better.In this episode of The Daily Mastermind, George Wright III sits down with Dr. Tracy Gapin — founder of Peak Launch and author of Male 2.0 — to break down why high performers are the most likely to ignore the symptoms quietly destroying their decisions, their leadership, and their longevity. And more importantly, exactly how to fix it.This isn't a conversation about being "healthy." It's about optimizing the biological systems that determine how you lead, decide, and perform under pressure.What You'll Learn:– Why high performers normalize feeling "off" — and why that gradual decline is so dangerous– The most common blind spots: low testosterone, cortisol dysfunction, and microbiome imbalance– Why traditional medicine's volume-based model keeps missing what high performers actually need– Dr. Gapin's "Test, Design, Track" system — advanced biomarkers, personalized plans, and wearables– What peptides actually are, how they work, and why sourcing matters more than most people know– How CGMs (continuous glucose monitors) reveal what no standard lab test can– Why sleep quality — not just duration — may be the single highest-leverage optimization available– How to treat proactive health as a core leadership and business strategy01:07 Why He Left Urology03:06 High Performers Focus04:31 Feeling Off Explained07:01 Blind Spots: Hormones & Gut08:42 Stress and Entrepreneur Myths11:03 Why Doctors Are Behind the Science13:29 The Test, Design, Track System16:41 Key Biomarkers to Test18:20 Peptides: Safety Basics21:45 Tracking Outcomes and the App24:08 Wearables, CGMs & Sleep27:23 Cortisol and Night Wakeups29:10 Health as a Business Strategy30:24 The Future: AI and Individualized MedicineThanks for listening, and Please Share this Episode with someone. It would really help us to grow our show and share these valuable tips and strategies with others. Have a great day.George Wright III“It's Never Too Late to Start Living the Life You Were Meant to Live”FREE Daily Mastermind Resources:CONNECT with George & Access Tons of ResourcesGet access to Proven Strategies and Time-Test Principles for Success. Plus, download and access tons of FREE resources and online events by joining our Exclusive Community of Entrepreneurs, Business Owners, and High Achievers like YOU.Join FREE at DailyMastermind.comFollow me on social media Facebook | Instagram | Linkedin | TikTok | YoutubeGrow Your Authority and Personal Brand with a FREE Interview in a Top Global Magazine HERE.About the Guest:Dr. Tracy Gapin is a renowned physician, TEDx speaker, and the founder of Peak Launch, a precision performance medicine practice dedicated to helping high-achieving men and women optimize their health. With over 25 years of medical experience and as the author of Male 2.0, he specializes in using epigenetics and advanced diagnostics to restore energy and focus. Guest Resource:Website: https://drtracygapin.com/Instagram: https://www.instagram.com/drtracygapin/Facebook: https://www.facebook.com/drtracygapin/LinkedIn: https://www.linkedin.com/in/tracygapin/

Have you ever found yourself down a late night rabbit hole, adding something to your cart that promised to fix everything? It's never been easier to reach for the supplement, the protocol, the skincare your favorite influencer is praising. We're living in the most exciting time in wellness history. Peptide stacks, CGMs, red light therapy, cold plunges, biohacking tools… and a $6.8 trillion industry that keeps growing. Some of these innovations can genuinely improve our health and our lives. But somewhere in the middle of all this innovation and optimization, we started skipping steps. And I think we've lost the plot. No supplement stack can out-supplement poor sleep. No peptide replaces a meal made from real food. No gadget rewires a nervous system that's running on chronic stress and negative self-talk. You cannot build anything lasting on a shaky foundation. You need the fundamentals, the basics that will actually move the needle. In this episode, you'll learn: How your inner narrative directly impacts digestion and nutrient absorption The unglamorous habit that outperforms most cleanses, detoxes, and supplements Why one simple morning habit can improve your sleep A fun way to nourish every cell in your body The mindset shift that makes movement feel natural, not forced The two "essential nutrients" that can elevate your quality of life When the foundations are solid, everything else works better. Including all the latest wellness biohacks and innovations.   Resources Mentioned: Shift Your Inner Narrative Stress Less While Eating  More on 30 plants a week study Advanced Sleep Tips Walk Your Way to Clarity and Calm  EWG website: www.ewg.org Elise's favorite water bottle recommendation (non-plastic)   Learn More about Elise Museles: Rise & Shine Coaching Program (50% discount for podcast listeners) Food Story: Rewrite the Way You Eat, Think, and Live Website: elisemuseles.com Instagram: @elisemuseles Facebook: @elisemuseles

Social Media Is Confusing Your Patients. In this episode, I'm joined by endocrinology PA Emily Stevens to discuss diabetes, insulin resistance, and blood sugar control and help you explain it in a way your patients will actually understand. If your patients are asking about glucose spikes, CGMs, keto, or supplements like berberine, this episode will give you clear, practical answers you can use in clinic this week.What You'll Learn: Why "glucose spikes" are normal and how to explain this to patients without causing fear  The truth about low-carb, keto, and intermittent fasting for diabetes management  Why telling patients to “cut carbs” or “avoid fruit” is wrong advice How to use the Diabetes Plate Method for quick, effective nutrition counseling  Why pairing protein + carbohydrates improves glycemic control (and how to teach it fast)  What the evidence says about berberine, magnesium, and supplements When lifestyle changes are enough vs when medication is necessary Who actually benefits from continuous glucose monitors (CGMs) (and who doesn't) Key Takeaways for the Exam Room:Blood sugar isn't meant to be flat. Help patients expect “rolling hills,” not a straight line. Carbs aren't the problem. Focus on quality, pairing, and portions. Start with beverages. It's often the fastest win for improving glycemic control. Don't demonize fruit. You'll create fear instead of sustainable change. Meet patients where they are. “Cut it in half” works better than “cut it out.” You can't out-supplement a poor diet. Food first, always. Use visuals, not numbers. The plate method > gram counting for most patients.Connect with EmilyAny Questions? Send Me a MessageSupport the showConnect with Colleen:InstagramLinkedInSign up for my FREE Newsletter - Nutrition hot-topics delivered to your inbox each week.Disclaimer: This podcast is a collection of ideas, strategies, and opinions of the author(s). Its goal is to provide useful information on each of the topics shared within. It is not intended to provide medical, health, or professional consultation or to diagnosis-specific weight or feeding challenges. The author(s) advises the reader to always consult with appropriate health, medical, and professional consultants for support for individual children and family situations. The author(s) do not take responsibility for the personal or other risks, loss, or liability incurred as a direct or indirect consequence of the application or use of information provided. All opinions stated in this podcast are my own and do not reflect the opinions of my employer. 

Host Eric Malzone sits down with Marco Benitez, CEO and Co-founder of ROOK — and former TaeKwondo champion turned biomedical engineer — to get real about where the fitness and wellness industry stands in the age of AI and wearable data. Marco pulls from his background at Roche and Novartis to explain why clean, unified data is the foundation everything else is built on, and why most operators are sitting on gold they don't know how to mine. From pharma clinical trials using Oura rings to track narcolepsy patients, to longevity brands leveraging sleep data to drive upsells, to the looming reality of AI agents reshaping how we interact with health professionals — this conversation doesn't sugarcoat anything. Eric and Marco also dig into the "dead internet" theory, AI hallucinations, self-driving cars, and why soft skills might be the most valuable thing you can develop right now. If you're in fitness, healthcare, or anywhere near the wellness space and you're not thinking seriously about your data strategy, this episode is your wake-up call. Key Takeaways:

Metabolic health is often simplified to a matter of blood sugar, but at its root, it is a complex system of energy substrate signaling. While many view chronic disease as an inevitable part of aging, a systems-thinking approach reveals that maintaining high "flux"—the capacity to efficiently move and clear energy through the body—is the primary lever for longevity. Without the stimulus of regular movement, even the most optimized diet can fail to prevent the accumulation of metabolic waste that leads to insulin resistance and heart disease.In this episode, we sit down with Greg Mushen, a technologist who turned his engineering mind toward his own biology after conventional medicine failed to address his chronic health issues. Mushen breaks down his "Theory of Flux" and why he believes the key to disease resistance lies in meeting our body's "clearance burden". From studying the activity levels of hunter-gatherer populations to debunking myths about walking and V2 max, Mushen provides a data-driven framework for optimizing health through the lens of evolutionary biology and systems engineering.Sign Up to Get Your Free Ultimate Guide to Glucose: ⁠⁠⁠⁠⁠⁠https://levels.link/wnl⁠⁠⁠⁠⁠In this episode, we cover:The Theory of Flux: Understanding health as the dynamic capacity to move nutrients and fuel through the system rather than a static set of markers.Insulin Resistance Reimagined: Why blood sugar is a symptom, not the root cause, and how fat accumulation in the liver and muscle disrupts signaling.The Power of PAL: Why a Physical Activity Level (PAL) of 2.0 is the "golden ratio" observed in disease-free subsistence populations.Walking vs. HIT: De-bunking the idea that you need high intensity to improve V2 max and why the "area under the curve" for oxygen consumption is what matters.The Saturated Fat Paradox: Comparing the Messiah and Chimané populations to understand how high activity levels can mitigate the risks of high-fat diets.Fiber as a Sensor: Why fiber is more than just "throughput" and acts as a critical environmental sensor for metabolic signaling.The "Walking Grifter" Philosophy: Why walking is the most under-leveraged tool for increasing metabolic flux with the lowest recovery cost.

Plus size fashion news, brands I refuse to give my money to, and ranting about a new Serena Williams commercial promoting a CGM as a "wellness hack." 

A $50 sensor on your arm, real-time data on your phone. The question isn't whether CGMs work. It's whether they're right for you. In this episode, Jeff takes a clear-eyed look at continuous glucose monitors. After wearing one revealed his own pre-diabetes, he spent years sorting the signal from the noise. Here's what CGMs show, what they miss, and who should actually use one. Inside the episode: How CGMs work, and why the 8 to 10% error margin matters Why your CGM is secretly one of the most honest stress monitors you can wear The glucose numbers worth knowing (and the ones to ignore) Why insulin resistance can precede a glucose spike by years The four CGM archetypes: Optimizer, Controller, Outsourcer, Curious Tourist The four biomarkers to check before you strap one on This episode is for anyone thinking about metabolic health, pre-diabetes, insulin resistance, or whether a continuous glucose monitor belongs on their arm. This episode was made possible by: Bon Charge: Get 15% off when you order at boncharge.com and use promo code COMMUNE LMNT: Get a free 8-count Sample Pack of LMNT's most popular drink mix flavors with any purchase at drinklmnt.com/commune. Vivobarefoot: Try Vivobarefoot risk-free with a 100-day return guarantee, and get 15% off your order at vivobarefoot.com/commune. Beyond Biohacking: Save $400 on any ticket with code COMMUNE400 at beyondconference.com. Sunlighten:  Visit sunlighten.com/commune  Up to 2,100 off saunas and $50 off Red Light Products with code “COMMUNE”

If midlife wellness feels overwhelming, you're not imagining it.Everyone has an opinion. Every scroll brings a new protocol. Eat this. Don't eat that. Lift heavier. Do less. Fix your hormones. Try this supplement.And most women? They're trying to do all of it—and still not feeling better.In this episode of Asking for a Friend, Michele sits down with Raquel Cartagena and Kristin Brucker, hosts of the Functional Moms Podcast, to cut through the noise and have an honest conversation about what it really takes to feel good in midlife.This is not a surface-level conversation. It's real, nuanced, and at times uncomfortable—because the truth is, there is no one-size-fits-all solution.We cover: Why midlife health feels so confusing and overwhelming  The biggest missing piece for women over 40 (and it's not another diet)  Functional medicine vs. traditional health approaches  The reality behind GLP-1s—benefits, concerns, and real-world experiences  Blood sugar, CGMs, and why “healthy foods” don't always work for your body  Fiber, protein, and the habits that actually move the needle  Alcohol in midlife—and the trade-offs most women ignore  Hormone replacement therapy (HRT): what to consider and why it's not one-size-fits-all  Supplements: what actually matters vs. what's just noise  Longevity strategies to stay strong, capable, and independent This episode is about taking your power back—learning to filter the noise, understand your body, and build a lifestyle that actually works for you.Functional Moms - https://functionalmoms.com/https://www.instagram.com/functionalmomspodcast/Save 25 percent off every supplement order courtesy of the Functional Moms:Functional Moms Fullscript StoreMichelle Doel and Alicia HardingMetabolism Mastery Class with CGMhttps://www.instagram.com/metabolism_mastery_coaches/https://metabolism-mastery.com/_________________________________________If you're doing “all the right things” and still feel stuck, adding a layer of support may be an option. I've partnered with a trusted telehealth platform offering modern solutions for women in midlife—including micro-dosed GLP-1 and other peptide therapies.https://elliemd.com/michelefolan - Create a free account to view all products.Follow us on Instagram https://www.instagram.com/askingforafriend_pod/✨ Sign up for my weekly newsletter: https://michelefolanfasterway.myflodesk.com/i6i44jw4fqLike to connect? Email me at askingforafriendpodcast1@gmail.com Transcripts are created with AI and may not be perfectly accurate.Disclaimer: This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing, or other professional healthcare services. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your qualified healthcare provider with any questions regarding a medical condition.

Mike Collins has been completely sugar-free for over 35 years. He is the founder of SugarDetox.com and SugarAddiction.com, past chairman of the board of the Food Addiction Institute, and the creator of the Quit Sugar Summit. He has helped over 60,000 people break their sugar dependency and has spent a decade interviewing more than 400 of the world's leading experts on sugar, addiction, and metabolic health. He and his wife raised two children without sugar until the age of six, and both of his sons scored perfect on their college entrance exams.This is one of the most eye-opening episodes we've done on this show. Sugar isn't a willpower problem. It's a brain chemistry problem, and Mike explains exactly why, and what to do about it.In this episode, we cover:Why sugar addiction is the largest substance use disorder the world has ever known — and why it's not your faultHow sugar affects dopamine, serotonin, GABA, oxytocin, endorphins, and every brain reward chemical — not just oneThe connection between sugar, drugs, and alcohol — and why so many people in recovery can't put sugar downWhy sugar stunts emotional development starting in childhood — and how it compounds over a lifetimeHow Mike's mother's story explains why so many of us learned to equate sugar with love, comfort, and rewardSugar as the "good girl's drug" — why women ages 50–80 make up 95% of his clients and what that says about people-pleasing and emotional soothingWhy "eat less, exercise more" is a $78 billion lie that doesn't address the actual problemThe difference between conditioned guilt, emotional eating, and true sugar addictionWhat dopamine dysregulation actually means — and whether those receptors can come backHis 90-day approach to behavioral change and why he calls it a recovery program, not a dietGLP-1s, Ozempic, and why the most interesting research will be about what they're doing to the brain — not the bodyWhy over-supplementing may be stalling your weight loss — and what the liver has to do with itContinuous glucose monitors (CGMs), how to use one, and his free book CGMs for Everybody on AmazonAlzheimer's, brain clarity, and why he believes sugar is a neurotoxinThe journaling practice he recommends — tracking how you felt before and after eating, not just what you ateWhat to say to yourself when a craving hits — and the simple self-check that changes everythingConnect with MikeWebsite: https://sugardetox.com Instagram: https://www.instagram.com/realsugarfreeman/YouTube: https://www.youtube.com/@SugarAddictionPlease remember to rate, review, and follow the show – and share with a friend!Subscribe to the newsletter:https://mailchi.mp/amyedwards/sign-up-to-amys-newsletterCheck out our new Comedy Wellness Podcast: Anything But Mid, cohosted with Whitney Stropp:https://podcasts.apple.com/us/podcast/anything-but-mid/id1849386215https://www.youtube.com/@AnythingButMidFind Amy's affiliates and discount codes: https://amyedwards.info/affiliatepageAll links: ⁠⁠⁠amyedwards.info⁠⁠⁠Instagram: ⁠⁠⁠@realamyedwards⁠⁠⁠Fight For Her: ⁠⁠⁠fightforher.net⁠⁠⁠TikTok:⁠⁠⁠ @themagicbabe⁠⁠⁠YouTube: ⁠⁠⁠YouTube Channel⁠⁠⁠Podcast: ⁠⁠⁠The Amy Edwards Show Podcast⁠⁠⁠Free Course:⁠⁠⁠ The Ageless Mindset⁠⁠⁠Full Course: ⁠⁠⁠The Youthfulness Hack⁠⁠⁠Amy's hair by ⁠https://www.thecollectiveatx.com⁠Podcast editing by https://podcastmagician.com/Get my FREE course "The Ageless Mindset: The Ultimate Guide to Look Younger and Feel Happier!" HERE: ⁠https://best-you-life.teachable.com/p/the-ageless-mindset-the-ultimate-guide-to-look-younger-feel-happier⁠Get the full course “The Youthfulness Hack: The Secret System to Reverse Aging Fast and Create a New, Radiant You!” Out now! ⁠https://best-you-life.teachable.com/p/the-youthfulness-hack⁠

This episode explores Penny's journey with chronic health issues, the pitfalls of relying solely on continuous glucose monitors (CGMs), and the importance of understanding individual physiology and electrolytes. It emphasises critical thinking, personalised health strategies, and the role of simple, effective nutrition solutions like sardine tortillas.Chapters00:00 Introduction and Penny's Background00:29 Penny's Health Journey and Use of CGMs01:17 The Problems with Interstitial Fluid Glucose Measurement02:15 Misleading Symptoms and Blood Glucose Readings03:12 Physiology of Interstitial Fluid and Blood Glucose04:10 Metabolic Differences and Device Calibration Issues05:08 Symptoms vs. Actual Blood Glucose Levels06:06 Electrolyte Imbalance and Its Symptoms07:29 The Critical Role of Potassium and Calcium08:24 Electrolyte Depletion in Low Carb and Carnivore Diets09:52 Penny's Sardine Tortilla Solution10:49 Nutritional Benefits of Sardines and Eggs11:15 Technology as a Tool, Not a Brain12:14 Chasing Numbers vs. Listening to Your Body13:11 The Nervous System and Electrolyte Balance14:36 Lessons Learned: Question Data and Trust Your Symptoms15:32 The Power of Individualised, Contextual Health Strategies16:00 Courage and Engaged Participation in Health

Episode SummaryWhat happens when life throws you something unimaginable… and you decide to rise anyway?In this episode, Simone sits down with GLP-1 Boost Lab client Candice Percy, who shares her deeply personal and inspiring journey of releasing 17 pounds—all while navigating a cancer diagnosis.Candice opens up about what made this time different:not another start-over moment… but a complete shift in identity, consistency, and support.From using real-time data like CGMs and Oura rings, to mastering simple habits like fiber-first eating and nutrient timing, Candice reveals how she stayed grounded, focused, and committed—even during one of the hardest seasons of her life.This is more than a transformation story.It's a conversation about resilience, mindset, and what's truly possible when you stop negotiating with yourself.Key Takeaways• Accountability changes everythingSmall group coaching created structure, consistency, and support when it mattered most.• Data creates awareness → awareness creates changeUsing tools like CGMs and Oura rings helped Candice understand her body in real time.• Simple strategies > extreme approachesNutrient timing and eating fiber first helped stabilize blood sugar and reduce cravings.• Mindset is the foundationCandice's identity statement:• “I don't negotiate with myself.”became her anchor in moments where it would've been easy to quit.• Consistency beats perfectionEven during treatment and stress, showing up in small ways created real results.Standout Moment“I don't negotiate with myself.”A simple sentence… but one that completely changed how Candice showed up for her health, her habits, and her life.Why This Episode MattersThis episode is a reminder that:• You don't need perfect conditions to make progress• Your environment and support system matter• And even in the hardest seasons… you can still move forwardIf this story resonated with you…It might be time to stop starting over—and start doing things differently.• Learn more about GLP-1 Boost Lab• Start understanding your body in real time• And build the habits that actually stick

In this episode I sat down with metabolic researcher Andrew Koutnik to break down the science of metabolic health, insulin resistance, and ketogenic diets. We explore why most people struggle with energy crashes, cravings, and weight loss resistance, and how blood sugar regulation plays a central role in long term health. Andrew shares insights from decades of research and personal experience living with type 1 diabetes, including how the body adapts to carbohydrate reduction, what metabolic flexibility actually means, and why keto is often misunderstood.→ Leave Us A Voice Message!  Topics Discussed: → What is metabolic flexibility and why does it matter? → How long does it take to adapt to a ketogenic diet? → Does keto improve insulin resistance and energy levels? → Why do people feel tired when starting low carb diets? → What is the best way to balance blood sugar naturally? Sponsored By:  → LMNT | Get a free 8-count Sample Pack of LMNT's most popular drink mix flavors with any purchase at https://drinklmnt.com/Kelly. Find your favorite LMNT flavor, or share with a friend. → Be Well By Kelly Protein Powder & Essentials | Get $10 off your order with PODCAST10 at https://bewellbykelly.com. Timestamps:  → 00:00:00 - Introduction → 00:01:37 - Diabetes + Nutrition  → 00:06:41 - Obesity + Insulin → 00:10:32 - Glucose Spikes  → 00:14:51- CGMs  → 00:15:28 - Blood Sugar Red Flags  → 00:19:30 - Reducing Carb Intake → 00:28:52 - Defining Metabolic Health → 00:34:00 - Meal Timing → 00:38:22 - Intermittent Fasting → 00:41:20 - Ketosis + Metabolic Flexibility  → 00:46:50 - Nutrition Experimentation → 00:50:59 - Nutrition Fundamentals → 00:55:50 - Food Swaps  → 01:01:51 - Performance Changes  → 01:06:27 - Sodium + Children's Snack  → 01:13:24 - Children's Sugar Intake  → 01:16:25 - Children's Nutrition  Further Listening:  → Why You're Always Hungry + How to Fix It | Dr. Jason Fung Check Out Andrew: → Website  → Instagram  → YouTube Check Out Kelly: → Instagram → Youtube → Facebook

Protein is often hailed as the ultimate nutrient for health and longevity, but the science suggests it is only half of the equation. While social media influencers debate the minutiae of protein grams, researchers have found that the vast majority of protein's benefits are "baked in" only when combined with physical activity. Without the stimulus of exercise, even the most optimized protein intake fails to move the needle on muscle growth or chronic disease prevention.In this episode of A Whole New Level, Mike Haney sits down with Dr. Stuart Phillips, a researcher who has spent over 25 years at McMaster University studying the intersection of protein, exercise, and human health. Dr. Phillips breaks down why the current RDA for protein is likely too low for optimal health and why the methodology used to set those standards is decades out of date.Dr. Phillips explains the "brick wall" analogy of muscle turnover—where synthesis and breakdown are in a constant tug-of-war—and how lifting weights acts as the primary driver for "the bricklayers". From the impact of anabolic resistance in aging to the truth about protein timing and kidney health, he provides a grounded, data-driven perspective on how to maintain a functional reserve of muscle as we age.Sign Up to Get Your Free Ultimate Guide to Glucose: ⁠⁠⁠⁠⁠https://levels.link/wnl⁠⁠⁠⁠In this episode, we coverThe RDA Debate: Why the standard 0.8 g/kg recommendation is a "preventing deficiency" baseline rather than an "optimized health" target.The Power of Exercise: Why 80% to 90% of protein's benefits are dependent on physical activity.Muscle as a Storage Depot: Understanding muscle as a functional reserve that dictates disease resistance and survival.Anabolic Resistance: How inactivity and aging make our cells less efficient at using amino acids.The Myth of Timing: Why the "anabolic window" is more like a "garage door" that stays open much longer than once thought.Protein Quality & Source: Comparing animal vs. plant proteins and why the "food matrix" matters more than isolated powders.Kidney Health: De-bunking the 60-year-old hypothesis that high protein intake causes kidney damage in healthy individuals.

In this episode of The Body GrieversⓇ Club, Bri interviews dietitian and certified diabetes educator Kristie Messerli (The Type 2 Diabetes Nutritionist) about type 2 diabetes, insulin resistance, medication, and the shame and fear that often follow diagnosis. Kristie explains diabetes in lay terms, emphasizing insulin resistance as the underlying issue, genetics as a major driver, and the nuance beyond "cut carbs, lose weight, exercise more," especially for women already dieting and exercising. They discuss complications as largely tied to unmanaged diabetes, the reality that medication may still be needed as the pancreas becomes less efficient, and myths about reversal, prediabetes, and weight loss. Kristie also breaks down GLP-1s, cautions against CGMs for people without diabetes/prediabetes, and shares resources, including her Balanced Blood Sugar Method and provider training group. 03:19 Diabetes Explained Simply 06:14 Is Type 2 Your Fault? 12:54 Common Fears and Complications 17:56 Myth or Fact? 21:55 Hormones, Thyroid, and PCOS 29:36 Genetics Loads the Gun 31:45 Healing Trust With Food 43:03 GLP1s Explained 49:20 Medication Fear and Risks 55:58 Diabetes Shame and Culture 59:08 Resources and Next Steps   WANT MORE OF KRISTIE? Connect with Kristie on Instagram https://www.instagram.com/type2diabetes.nutritionist/  WANT MORE OF BRI? *Instagram: @bodyimagewithbri
 *Website: https://bodyimagewithbri.com/ *Bri's Free Resource: 7-Step Guide to Shift Body Grief to Radical Body Acceptance https://www.bodyimagewithbri.com/seven-steps 

How do we help patients improve health span without letting wearables, biomarkers, and wellness trends take over the conversation? Learn how to think about CGMs in patients without diabetes, how to interpret early cardiometabolic risk beyond the A1c, how to prescribe exercise in a practical way, and how to counsel patients about sleep, wearables, and even peptides. We're joined by Dr. Sandeep Palakadedi (Dr. “Deep”), founder and CEO of Velocity Health and author of The Ultimate Asset.Claim CME for this episode at curbsiders.vcuhealth.org!Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CMEShow Segments Intro CGMs, Postprandial Glucose, and Data Neurosis Beyond Glucose: ApoB, Lp(a), and Early Cardiometabolic Risk Body Composition, VO2 Max, and Functional Longevity Sleep, HRV, and Wearables Prescribing Exercise in Real Life How to Talk to Patients About Peptides Take-Home Points CreditsWritten and produced by Paul Wurtz MD. Show notes, cover art, and infographic also created by Paul Wurtz MD. Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP    Reviewer: Sai S Achi MD, MBA, FACP Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Guest: Sandeep Palakodeti MD, MPH DisclosuresDr. Palakodeti reports no relevant financial disclosures. The Curbsiders report no relevant financial disclosures. Sponsor: MINT MOBILEShop plans at MINTMOBILE.com/CURB.Sponsor: FIGSWe've teamed up with FIGS, and now Curbsiders listeners can get 15% off. Just go to WearFIGS.com and use code FIGSRX. Sponsor: Continuing Education CompanyFor Curbsiders listeners, there's a special offer: use promo code Curb30 for 30% off all online courses and webcasts. Visit CMEmeeting.org/curbsiders to learn more.  

Modern medicine has come a long way in its fight against diabetes. We now have continuous glucose monitors (CGM) and automated insulin delivery (AIDs) systems. These have revolutionized patient care. The FDA has approved devices for use in pregnancy as “nonadjunctive use” (meaning they may be used alone), although capillary finger stick assessments are currently still considered the Gold Standard. While the most robust data in support of CGMs is for preexisting Type 1 DM (Class B or beyond) and Type 2, there is recent growing support for CGM use in GDM patients, although some limitations still apply. Listen in for details.1. Feig DS, et al; CONCEPTT Collaborative Group. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet. 2017 Nov 25;390(10110):2347-2359. doi: 10.1016/S0140-6736(17)32400-5. Epub 2017 Sep 15. Erratum in: Lancet. 2017 Nov 25;390(10110):2346. 2. Benhalima K, Durnwald C, Sweeting A et al.Application of continuous glucose monitoring and automated insulin delivery technologies for pregnant women with type 1, type 2, or gestational diabetes: an international consensus statementThe Lancet Diabetes & Endocrinology, 2025; 14, 157-1773. Salmen BM, Reurean-Pintilei D, Salmen T, Bohîlțea RE. Exploring Continuous Glucose Monitoring in Gestational Diabetes: A Systematic Review. Life (Basel). 2025 Aug 28;15(9):1369. doi: 10.3390/life15091369. PMID: 41010309; PMCID: PMC12470761.4. Wyckoff JA, Lapolla A, Asias-Dinh BD, et al.Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline. The Journal of Clinical Endocrinology and Metabolism. 20255. American Diabetes Association Professional Practice Committee for Diabetes*; 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2026. Diabetes Care 1 January 2026; 49 (Supplement_1): S321–S338. https://doi.org/10.2337/dc26-S0156. Burk J, Ross GP, Hernandez TL, Colagiuri S, Sweeting A. Evidence for improved glucose metrics and perinatal outcomes with continuous glucose monitoring compared to self-monitoring in diabetes during pregnancy. Am J Obstet Gynecol. 2025 Sep;233(3):162-175. doi: 10.1016/j.ajog.2025.04.010. Epub 2025 Apr 10. PMID: 40216177.7. Linder T, et al; GRACE study collaborative group. Glycaemic control and pregnancy outcomes with real-time continuous glucose monitoring in gestational diabetes (GRACE): an open-label, multicentre, multinational, randomised controlled trial. Lancet Diabetes Endocrinol. 2026 Jan;14(1):50-61. doi: 10.1016/S2213-8587(25)00288-8. Epub 2025 Nov 24. PMID: 41308662.8. Valent AM, et al. Real-Time Continuous Glucose Monitoring in Pregnancies With Gestational Diabetes Mellitus: A Randomized Controlled Trial. Diabetes Care. 2025 Sep 1;48(9):1581-1588. doi: 10.2337/dc25-0115. PMID: 40730104; PMCID: PMC12368369.9. Kusinski LC, et al. Continuous Glucose Monitoring Metrics and Pregnancy Outcomes in Women With Gestational Diabetes Mellitus: A Secondary Analysis of the DiGest Trial. Diabetes Care. 2025 Aug 19:dc250452. doi: 10.2337/dc25-0452. Epub ahead of print. PMID: 40828742; PMCID: PMC7618813.10. García-Moreno RM, et al. Efficacy of continuous glucose monitoring on maternal and neonatal outcomes in gestational diabetes mellitus: a systematic review and meta-analysis of randomized clinical trials. Diabet Med. 2022 Jan;39(1):e14703. doi: 10.1111/dme.14703. Epub 2021 Oct 13. PMID: 34564868.11. Amylidi-Mohr Set,.et al (DipGluMo): an open-label, single-centre, randomised, controlled trial. Lancet Diabetes Endocrinol. 2025 Jul;13(7):591-599. doi: 10.1016/S2213-8587(25)00063-4. Epub 2025 May 26. Erratum in: Lancet Diabetes Endocrinol. 2026 Mar;14(3):e6. doi: 10.1016/S2213-8587(25)00403-6. PMID: 40441173.

Most people treat their skin like a surface problem. But almost every persistent skin issue, from rosacea to eczema to accelerated aging, has something deeper driving it.That deeper driver is almost always the gut, the liver, or a backed-up detox pathway. We at Young Goose, always believe that skincare is whole body care and we want our community to identify the deeper causes of skin issues that products alone can't fix.In this episode, functional nutrition practitioner Dani Conway joins us to break down why the skin is not the origin of the problem but the exit sign. When the body cannot eliminate toxins efficiently, they take the path of least resistance. For a lot of women, that path is the skin on their faces.Dani brings nearly 20 years of clinical practice to this conversation, along with a sharp, evidence-grounded perspective on why fixing hormones first is often the wrong starting point and what to address instead.We go deeper into this in the latest episode of Biohacking Beauty: The Anti-Aging Skincare Podcast. We also cover how to deal with food sensitivities, common misconceptions around hormones and blood sugar testing, and the use of GLP-1 and peptide use. Let's dive in!What's Discussed:(0:57) How poor detoxification shows up on the skin.(2:09) The foundational actions to support detox.(5:44) The lymphatic system explained.(6:33) Why Dani stopped addressing hormones first.(8:01) Microplastics, endocrine disruptors, and chemicals women apply to their skin. (11:40) The gut-skin axis: How gut symptoms always end up on your face.(13:55) NAD, CD38, and why a bacterial infection in your gut affects cell energy. (16:59) Why peptides and NAD supplements don't work if the foundation isn't dialed in first.(21:26) Can you actually fix hormones or just manage them?(25:12) Real-world food sensitivity examples and how to figure out your personal triggers. (29:41) How to run an elimination diet correctly.(34:39) The big picture nobody talks about: it's not the food, it's the immune system.(36:06) The new science on acne: The bacteria and immune system response.(38:06) Hot take: Why immune optimization is the next mitochondria.(39:49) CGMs and skin aging: Why Dani actually pulls clients back from data obsession. (42:09) Fasting insulin ranges: Why the lab's "normal" range is dangerously wide.(43:35) The role of GLP-1s and how to use them as a therapy instead of a crutch. (45:12) Dani's hot take on berberine and leptin resistance.Find more from Young Goose:Use code PODCAST10 to get 10% off your first purchase, and if you're a returning customer use the code PODCAST5 to get 5% off at https://younggoose.comInstagram: @young_goose_skincareFind more from Dani Conway:Instagram: @DaniConwayOfficialWebsite: https://nutritionthenaturalway.com/The Wellness Collective: https://nutritionthenaturalway.com/drop-the-weight-shred-the-fat/Weight Loss Accelerator Program: https://go.nutritionthenaturalway.com/wlaFree Complimentary Guide: https://go.nutritionthenaturalway.com/hhh

Today, we're diving into a hot topic that's been popping up all over social media, wellness circles, and maybe even your group texts: blood sugar monitoring—specifically CGMs, or continuous glucose monitors.Maybe you've seen influencers or health coaches wearing them, tracking every spike and dip. Maybe you've thought, "Should I be doing that too?" Or maybe you're just wondering, “Is sugar really that bad for me?”This episode is all about cutting through the noise. I'll break down what blood sugar is, why it matters, whether CGMs are necessary, and how to keep your blood sugar steady without obsessing over every bite.Free GUIDESWork with me through NOURISH nutrition consulting

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.In this episode, Coach Ken and Graham dive into a real, unfiltered conversation that blends everyday life with powerful updates in diabetes care.From late-night home disasters to frustrating CGM issues, this episode starts off relatable—but quickly shifts into something much bigger: what's changing in diabetes management and access to care in 2026.They break down new updates from the American Diabetes Association, including recommendations around CGMs at diagnosis, reduced barriers to insulin pumps, and evolving treatment approaches.More importantly, Ken shares a strong perspective on what truly matters—balancing education with real-life support, especially for those newly diagnosed or caregivers navigating the early stages of diabetes.This episode is a reminder that while technology is improving, the real challenge is still learning how to apply it confidently in your everyday life.

How Continuous Glucose Monitors Can Optimize Metabolic Health—and Where GLP-1 Drugs Fit: Emergency physician-turned-preventive/metabolic medicine specialist Dr. Paul Kolodzik of Metabolic MD reveals how continuous glucose monitors (CGMs) are a tool not only for diabetics but also for non-diabetics and pre-diabetics to personalize diet, sleep, and exercise by seeing real-time glucose patterns instead of relying on fingersticks or A1c averages. Kolodzik describes CGM use in his clinic (two-week diagnostic wear, then therapeutic guidance), highlights insulin resistance, fasting insulin testing, glucose variability, and the role of low-carb eating, intermittent fasting, and strength training to improve metabolic syndrome, triglycerides, and fatty liver. They discuss CGM sourcing/cost, device mechanics and accuracy, possible future noninvasive wearables, and GLP-1/GIP weight-loss drugs, emphasizing supervised, limited-dose use with protein and lifestyle changes to avoid muscle loss and weight regain. A free PDF of Kolodzik's book is offered HERE.  

Employers keep paying for the symptoms of obesity, diabetes, and metabolic syndrome while the root causes go untouched. We unpack why many wellness models fail, how insulin resistance hides for years, and what chronic disease reversal can look like when a physician-led metabolic health team measures the right signals and tapers meds safely. • metabolic syndrome as a dominant driver of employer healthcare costs • why low-fat guidance and ultra-processed food worsen hunger and outcomes • fasting insulin and CGMs as earlier and more actionable markers than glucose alone • nutritional ketosis versus diabetic ketoacidosis and why the terms get conflated • GLP-1 medication costs plus the idea of a structured GLP-1 off-ramp • reported outcomes including weight loss and guaranteed improvements in A1C and blood pressure • deprescribing as a safety requirement when health improves quickly • ROI logic for self-funded plans including claims reduction and lower pharmacy spend Call my cell phone, 262-255-9545. brett@toward.health

Yet more GLP1 news this week.  People regain on average 60% of their lost weight within a year of stopping GLP-1 drugs — and the regained weight may be disproportionately fat rather than muscle.  So are a tool that biohackers have known about for years - CGMs - the answer?  Sharam Fouladgar-Mercer is the co-founder of Signos, the first ever FDA-cleared glucose system for weight management. Follow Sharam Fouladgar-Mercer on LinkedIn.

Preconception health is one of the most powerful—yet overlooked—windows for influencing a child's lifelong wellness. While fertility is often discussed in the context of age or medical intervention, emerging research suggests that the months leading up to conception are a critical "time capsule" for epigenetic health.In this episode of A Whole New Level, Levels Founder and CEO Josh Clemente sits down with Dr. Anne Shippy, a board-certified internal medicine physician and author of The Preconception Revolution. Dr. Shippy brings a unique, systems-based approach to fertility, moving beyond basic labs to uncover the root causes of infertility and chronic disease.Dr. Shippy explains why the "check engine light" of infertility is often a signal of deeper metabolic or environmental imbalances—and why age isn't always the primary driver of reproductive success. Drawing on her engineering background and years of clinical practice, she walks through how toxins, mitochondrial function, and the microbiome interact to shape the health of both parents and their future children.Along the way, the conversation explores the practical "mini-experiments" couples can run to optimize their biology—from tightening blood sugar control with CGMs to auditing the "chemical soup" of modern life. The result is an empowering framework for generational health: shifting the focus from reactive treatments to proactive, data-driven preparation.Sign Up to Get Your Free Ultimate Guide to Glucose: ⁠⁠⁠⁠https://levels.link/wnl⁠⁠⁠In this episode, we cover• The Preconception Window: Why the 3–12 months before pregnancy are a critical window for epigenetic influence• The Engineering Approach: Applying systems-based, data-driven models to the biochemistry of the body• Environmental Toxins: How PFAS, phthalates, and microplastics in packaging disrupt hormone health• Sperm Health Trends: Understanding the 50% decline in sperm counts and the role of lifestyle in reversing damage• Mitochondrial Function: Why cellular energy production is the foundation of egg and sperm quality• IVF as a Last Resort: Why tuning up the body's "hospitable environment" should come before invasive procedures• The Role of Glucose: How stable blood sugar improves fertility and passes on better epigenetics to the baby

It's In the News, a look at the top headlines and stories in the diabetes community. This week's top stories: Metformin may help stem macular degeneration, retatutride moves forward, T1D and demntia link studied, lots of news from ATTD and more! Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  transcript with links:  Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bringing you the top diabetes stories and headlines happening now. A reminder that you can find the sources and links and a transcript and more info for every story mentioned here in the show notes. Who's in Vegas? I'll see you there at the Breakthrough T1D summit this weekend. And we have two Club 1921 events for health care providers and patient leaders happening in April – head on over to the website for more. Okay.. our top story this week: XX Metformin may be linked to the slower progression of age-related macular degeneration (AMD). Among people with diabetes who were older than 55, those taking metformin had a 37% lower chance of developing intermediate AMD over a five-year period compared with individuals who were not using the medication. It's one of the leading causes of vision loss in the US and many other western countries. These researchers now say a clinical trial is the next step. https://scitechdaily.com/scientists-discover-surprising-eye-benefit-of-widely-used-diabetes-drug/ XX new study suggests people with type 1 diabetes may be nearly three times as likely to develop dementia compared with people without diabetes. Similarly, people with type 2 diabetes may have roughly twice the risk of dementia compared with those without diabetes. However, the study found an association rather than proof of causation, meaning diabetes was linked to dementia risk but was not shown to directly cause it.   https://www.usnews.com/news/health-news/articles/2026-03-19/both-types-of-diabetes-increase-dementia-risk XX Researchers in Japan say they've developed an insulin pill… in mice.  The study, published in the journal Molecular Pharmaceutics, tested the delivery of oral insulin by building a carrier peptide called DNP-V. This peptide helps to transport insulin through the small intestine, where protein drug absorption is usually poor. The result was a rapid and significant drop in blood glucose, as well as a sustained (longer-term) decrease. The mice's blood sugar was reduced to near-normal levels. Although the researchers are optimistic about the findings translating to larger therapeutic models, they noted that the results in mice do not guarantee the same outcome in humans, and that more research is needed. https://www.foxnews.com/health/needle-free-diabetes-management-could-horizon-study-suggests   XX   Lilly says it's next-generation obesity drug retatutride cleared its first late-stage trial on Type 2 diabetes patients. The drug lowered hemoglobin A1C by an average of 1.7% to 2% across different doses at 40 weeks compared with placebo, and helped patients lose an average of 16.8% of their weight. Retatrutide also met the study's second goal, helping patients at the highest dose lose an average of 16.8% of their weight, or 36.6 pounds, at 40 weeks, when evaluating only patients who stayed on the drug. When analyzing all participants, including those who discontinued treatment, the highest dose of the drug helped patients lose 15.3% of their weight. The company was also "very pleased" with the relatively low discontinuation rates due to side effects, which were up to 5%, he added. But Lilly has yet to file for approval of the drug for obesity or diabetes. The company expects to report findings from seven additional phase three trials on the drug by the end of the year. Still, retatrutide's A1C reduction doesn't appear to be the greatest Lilly has seen within its portfolio: The highest dose of Zepbound lowered the measure by more than 2% at 40 weeks in two separate trials on diabetes patients. Dubbed the "triple G" drug, retatrutide works by mimicking three hunger-regulating hormones – GLP-1, GIP and glucagon – rather than just one or two like existing treatments. That appears to have more potent effects on a person's appetite and satisfaction with food than other treatments.   https://www.cnbc.com/2026/03/19/eli-lillys-obesity-drug-retatrutide-clears-late-stage-diabetes-trial.html XX   The MiniMed Flex gets FDA approval. Thi is a new design from the company formerly known as Medtronic. It's about half the size* of the MiniMed™ 780G pump, no screen – smartphone controlled – and has the SmartGuard™ algorithm with Meal Detection™ technolog. At commercial launch, MiniMed Flex™ will support the company's newest sensor portfolio, including Simplera Sync™ sensor and the Instinct sensor, made by Abbott. MiniMed also announced the MiniMed™ Forward Program, which allows customers who start on the MiniMed™ 780G system to upgrade to the MiniMed Flex™ system for $0. MiniMed Flex™ is cleared for individuals ages 7 and older with type 1 diabetes, and for individuals 18 years and older with insulin-requiring type 2 diabetes. https://www.prnewswire.com/news-releases/minimed-announces-fda-clearance-of-minimed-flex-the-companys-smallest-insulin-pump-featuring-its-first-smartphone-controlled-design-302716864.html   XX Lots of new out of the recent ATTD conference.. some headlines: New study from the UK shows that Ketone Monitoring Could Significantly Reduce DKA Risks in people with type 1 and type 2. This was a study by Abbott which recently submitted a continuous dual glucose-ketone monitor to the FDA for clearance – if approved, it could be available in the U.S. later this year. -- The first modified insulin producing cells are still working 14 months after transplant – without the need for immunosuppressive drugs. This is from Sana which now plans a study of a new therapy.. same gene-editing strategy with lab-grown, stem-cell-derived insulin-producing cells. -- Protein looks like it helps avoid lows during exercise. Both high and low doses of whey protein before exercise were effective, significantly reducing the risk of hypoglycemia by five to 10 times.   Researchers noted that the body's response to protein was rapid (within 20 minutes), which suggests taking it close to the beginning of exercise could be beneficial for preventing hypoglycemia. Though more research is needed, there was also evidence showing protein intake could be beneficial for prolonged fasting and preventing overnight lows. -- More info about type 1 and GLP medications. Researchers at ATTD presented the results of a small, seven-month study assessing the effectiveness of semaglutide for people with type 1 diabetes and obesity. During the trial, 36% of participants taking semaglutide spent more than 70% of their time in range, less than 4% of their time below range, and lost more than 5% of their body weight compared to those not taking semaglutide.   Treatment with semaglutide was also associated with reductions in cholesterol and blood pressure. Based on all of these changes, the researchers calculated that the participants who received semaglutide had significantly reduced their risk of heart disease over the next 10 years.   Other studies show that since 2020, prescriptions of GLP-1 medications have grown exponentially for adults with type 1 diabetes between the ages of 18 and 85. https://diatribe.org/diabetes-research/top-diabetes-news-attd-2026   XX Lots of talk about fully closed loops.. CamDiab unveiled theirs.. called Liberty.. which the company says it's the world's first fully closed loop commercial launch. CamDiab offers the FDA-approved mylife CamAPS FX app for automating insulin delivery in MyLife's (formerly Ypsomed Diabetes Care's) insulin delivery pumps. The mylife CamAPS FX on iOS has full compatibility with leading continuous glucose monitors (CGMs). Those include the FreeStyle Libre 3 and Libre 3 Plus from Abbott and the Dexcom G6 so customers can use their preferred device. https://www.drugdeliverybusiness.com/camdiab-unveils-fully-closed-loop-insulin-feature/ XX Insulet reported data on a fully closed-loop automated insulin delivery system in people with Type 2 diabetes. The 24 people in the trial spent 24% more time in the target blood glucose range using the system than when receiving standard injection therapy. Insulet plans to start a pivotal study this year and aims to launch in 2028. Rival insulin pump manufacturer Tandem is on a similar course. Tandem CEO John Sheridan told investors on an earnings call last month that his team plans to start a pivotal trial this year to support a filing with the Food and Drug Administration in 2027. Medtronic disclosed the start of a pivotal trial of its Vivera fully closed-loop algorithm last month, shortly before spinning off the program as part of the MiniMed initial public offering. The algorithm, which is designed to eliminate carb counting and manual food bolusing, achieved a mean time in range of 73.8% without manual user input in a feasibility study.   https://www.medtechdive.com/news/insulet-posts-clinical-data-on-fully-closed-loop-insulin-delivery-system/814516/ XX Congrats to all honored by the 2026 National Scientific and Health Care Achievement Awards from the American Diabetes Association! Shout out to Diana Isaacs, PharmD, BCACP, BC-ADM, CDCES: 2026 Outstanding Educator in Diabetes Award and to  Korey Hood who receives the Richard Rubin award. Dr. Rubin was a pioneer in behavioral science and committed to keeping the person with diabetes at the center of research and care.

Megan O'Neill is a physician associate who spent years in clinical practice before finding her calling at the intersection of diabetes care and psychology. While working at the University of Kansas Medical Center, Megan discovered the work of leading diabetes psychology researchers and it changed her entire practice, her perspective, and her passion. That foundation eventually led her to Abbott Diabetes Care, where she has spent the last eight years advocating for the emotional and psychological side of living with diabetes to be treated with the same seriousness as the clinical data.In this conversation, Lauren and Megan dig into what diabetes distress actually looks like day to day — the exhaustion, the isolation, the feeling of doing everything right and still not getting the results you hoped for. They talk about why it often goes unrecognized in clinical care, how it differs from depression, and why a good A1C doesn't always mean you're okay. They also explore how CGMs can both reduce and sometimes complicate our emotional relationship with diabetes and what it actually takes to move the needle when distress is high.WHAT WE COVER:What diabetes distress really is, how it differs from depression, and why it is still significantly underutilized as a screening tool in clinical careWhy people with an A1C under 7 can still score in the moderate to high range on the diabetes distress scale and what that actually meansThe unequal energy exchange of T1D: putting in the effort but not getting the results, and why that cycle is so defeatingHow CGMs have overwhelmingly helped reduce distress and the honest acknowledgment that alarms and constant data can also add to it for some peopleWhat the research actually says about what helps most when someone is not reaching their diabetes goals: it is not just education or medication management aloneThe one tangible step you can take in the next 24 hours if any of this conversation resonated with youWHAT'S NEXT:

Blood sugar stability may be one of the most important levers for long term health, yet most people never look at it.In this episode, I am joined by Jessie Inchauspé, widely known as the Glucose Goddess, to examine what glucose spikes are actually doing inside the body and why they matter even if you are not diabetic.We unpack how glucose spikes can influence your mood, focus, cravings, and energy levels, why blood sugar stability matters even if you are not diabetic, and how seeing your own patterns can completely change the way you approach food.Join the most comprehensive *female-specific community for health and longevity optimization.* After over a decade dedicated to human performance and women's health, I created this space to share everything you need to know to optimize health and lifespan. Inside, you'll get access to exclusive protocols, live Q&As, the latest female longevity science, and a private, supportive community of like-minded women.https://kayla-barnes-lentz.circle.so/checkout/become-a-memberWe also cover:- The biggest glucose mistakes most people make- Why “healthy” breakfasts often lead to energy crashes- How dinner timing impacts deep sleep- The connection between glucose spikes and skin aging through glycation- Simple strategies like food order and walking after meals- How a mother's glucose levels can influence her baby's long term metabolic riskUnderstanding your glucose patterns gives you leverage, and small, strategic shifts can compound into measurable long term health improvements.Connect with Kayla:Instagram: https://www.instagram.com/kaylabarnes/TikTok: https://www.tiktok.com/@femalelongevityTwitter:https://x.com/femalelongevityWebsite:https://www.kaylabarnes.com/Spotify:https://open.spotify.com/show/4OLWWn22...Apple: https://podcasts.apple.com/us/podcast...Follow Her Female Protocol: https://www.protocol.kaylabarnes.comConnect with Glucose Goddess:Website: https://www.glucosegoddess.com/YouTube: https://www.youtube.com/@GlucoseRevolutionInstagram: https://www.instagram.com/glucosegoddess/TikTok: https://www.tiktok.com/@glucosegoddess_Pre-order her new book: https://www.glucosegoddess.com/pages/9-months-that-count-forever

Send us Fan MailThese days, federal funding can feel like a door slamming shut, in this episode, we sit down with Tonia Brown-Kinzel, grant compliance manager at The Grant Plant, to map what is actually happening in the federal grants landscape and what nonprofit leaders can do right now to stay competitive without losing themselves in fear or guesswork. We get concrete about grant compliance and grant management: how to kick off an award so everyone understands the scope, the budget, and the reporting plan; how to hold monitoring meetings that catch problems early; and how to avoid the “final report surprise” when nobody collected the outcomes data you promised. Tonia breaks down the most common compliance mistakes she sees with federal grants, including allowable costs, procurement rules and thresholds, subrecipient monitoring, and time and effort tracking. We also dig into funding strategy as priorities shift. Tonia shares what she is seeing across agencies, why private foundations and community foundations are under pressure as more nonprofits apply, and where opportunities may be growing, including infrastructure, economic development, STEM, AI, and congressionally directed spending and community project funding. The biggest mindset shift is simple: stay mission-true, then learn to frame your work in language decision-makers recognize and support it with the statute behind the program when needed.  Subscribe for more practical nonprofit guidance, then share this with a leader who is carrying too many hats. After you listen, leave a review and tell us: what part of compliance or funding strategy do you want unpacked next?Here is the resource Tonia mentioned for listeners to download: https://bit.ly/4lzxzaoGuest BioTonia Brown-Kinzel, GPC, CGMS, is the Grant Compliance Manager for The Grant Plant, Inc. She is a Grant Professionals Association (GPA) “Approved Trainer” with extensive public speaking and training experience. She serves on the national GPA Professional Education Committee, is the Board President of the GPA Ohio-Miami Valley Chapter, and is a member of the Ohio Chapter of the National Grants Management Association (NGMA). Tonia has a unique combination of experiences that yield special insights that have earned more than $20 million in funding for nonprofit organizations, Tribal nations, and municipal agencies over the course of her career. Tonia presents at numerous national and regional grant- and fundraising-related conferences and training workshops. She is holds the Grant Professional Certified (GPC) credential and the Certified Grants Management Specialist (CGMS) credential. She was selected as a “40 Under 4Like what you heard? Please like and share wherever you get your podcasts!Connect with Ann: Community Evaluation Solutions  How Ann  can help:·        Support the evaluation capacity of your coalition or community-based organization.·        Help you create a strategic plan that doesn't stress you and your group out, doesn't take all year to design, and is actionable.·        Engage your group in equitable discussions about difficult conversations.·        Facilitate a workshop to plan for action and get your group moving.·        Create a workshop that energizes and excites your group for action.·        Speak at your conference or event.Have a question or want to know more? Book a call with Ann .Be sure and check out our updated resource page! Let us know what was helpful.   Music by Zach Price: Zachpricet@gmail.com

Dr. Bret Scher, medical director of the Coalition for Metabolic Health, discusses making metabolic health the foundation of medicine amid rising obesity and type 2 diabetes and reports that 93% of Americans have suboptimal metabolic health. Scher defines metabolic health using markers including glucose, insulin, triglycerides, HDL, blood pressure, and waist size, and cites evidence linking insulin resistance to heart disease, stroke, cancer, psychiatric illness, and other complications. They discuss simple self- and lab-assessments (waist-to-height ratio, fasting insulin with glucose/HOMA-IR, triglyceride-to-HDL ratio, CGMs). Scher critiques the Eat Lancet report for assuming one optimal diet, reliance on low-quality nutrition epidemiology, potential nutrient shortfalls, and environmental oversimplification, while supporting newer dietary guidelines that allow lower-carb approaches. Part two covers contradictory nutrition studies, distinctions between low-carb and ketogenic diets, emerging “metabolic psychiatry” and ketogenic therapy for mental illness and cognitive decline, limits and rebound risks of GLP-1 drugs, and Coalition efforts to improve school food and influence policy.

Have you ever noticed someone wearing a little gadget on their arm and wondered what it was for? That small piece of technology is part of a fascinating shift in how we understand our own health.In today's podcast, we'll explore the world of personal health 'devices' like CGMs. We'll learn (https://adeptenglish.com/company/learning-system/) useful English vocabulary, including the words 'nutrition' and 'microbiome', and discuss how this science gives us personalised information about our bodies.Upgrade your listening experience. No ads, just pure British English learning. Get 8 exclusive premium episodes every month delivered straight to your phone.✨ Learn more (https://adeptenglish.com/faq/subscription-faq/)We'll look at why this new approach is exciting and also answer why some people in the medical world are questioning it. You'll hear about surprising discoveries that change standard health advice.And Don't forget to follow and subscribe to our FREE English language podcast, wherever you listen (https://adeptenglish.com/english/listening/) or watch your podcasts.

Which health protocols are actually worth your time vs. what's just trending?In this episode, Dr. Robin Berzin, founder of Parsley Health and a leading voice in functional medicine, offers a clear framework for navigating today's overwhelming wellness landscape. From GLP-1s and HRT to peptides and psychedelic therapy, they cut through the noise to answer one question: Is this right for me? Who's actually a good candidate for GLP-1s (and the DEXA scan step most people skip) HRT and testosterone for women in perimenopause: what the latest research says Peptides, CGMs, and microbiome tests (clinical utility vs. hype) Psychedelic therapy and ketamine: how to find trustworthy care Cold therapy, fasting, and biohacking protocols through a female lens Check out Dr. Robin Berzin's upcoming Body Lab: A Female Healthspan Immersion Retreat. This show is made possible by:Stemregen: Get 20% off your first order at stemregen.co/commune with the code COMMUNEPOD Bon Charge: Get 15% off when you order at boncharge.com and use promo code COMMUNE  Timeline: Go to Timeline.com/COMMUNE to claim a special offer for Commune listeners.  LMNT: Get a free 8-count Sample Pack of LMNT's most popular drink mix flavors with any purchase at drinklmnt.com/commune. CBDistillery: Go to CBDistillery.com  and use code COMMUNE for 25% off. 

High cholesterol is one of the most widely discussed—and established—risk factors in medicine. But reams of research now show that while it is key to cardiovascular risk, it is not the whole story.In this episode of A Whole New Level, editorial director Mike Haney sits down with Dr. Ronald Krauss, one of the world's leading lipid researchers and a pioneer in understanding how different forms of LDL—and the physiological factors around them—affect cardiovascular risk.Dr. Krauss explains why the basic link between cholesterol and heart disease is well established among experts—but also why the standard cholesterol panel often misses the deeper metabolic story. Drawing on decades of research, he walks through how lipoproteins, particle size, triglycerides, and metabolic health interact to determine whether cholesterol actually becomes dangerous.Along the way, the conversation explores why cardiovascular disease remains the leading killer despite statins and decades of research—and how factors like obesity, insulin resistance, and inflammation reshape the lipid landscape in ways that traditional tests may not capture.The result is a clearer framework for understanding cardiovascular risk: not just how much cholesterol is in the blood, but how it's being transported, how long those particles circulate, and what metabolic conditions are driving them.Sign Up to Get Your Free Ultimate Guide to Glucose: ⁠⁠⁠https://levels.link/wnl⁠⁠In this episode, we coverWhy the cholesterol–heart disease link isn't actually controversial among researchersCholesterol vs. lipoproteins: why the particles carrying cholesterol matter more than the number itselfSmall dense LDL: how triglyceride metabolism produces the most harmful particlesApoB and particle counts: why many researchers prefer measuring particles instead of cholesterol massLipoprotein(a): the genetically driven risk factor affecting up to a third of the populationMetabolic syndrome: the cluster of conditions that amplifies cardiovascular riskWhy carbohydrates and metabolic dysfunction can drive harmful lipid patternsThe saturated fat debate: why food context and metabolic health matter more than simple fat categories

In this episode, Dr. Eric talks with certified nutritionist and menopause specialist Leah Vachani about blood sugar imbalances, insulin resistance, and how these issues often show up long before a diagnosis of prediabetes or type 2 diabetes. Leah shares how her work with women in perimenopause and menopause led her to see blood sugar as a major missing piece in hormone health, energy, sleep, and weight regulation.Together, they explore why stress, poor sleep, processed foods, and hormone shifts can all contribute to unstable blood sugar. Leah also explains how continuous glucose monitors can help people see their individual patterns more clearly, from food triggers to stress spikes, while also discussing the limits of CGMs, fasting insulin, A1C, protein intake, apple cider vinegar, intermittent fasting, and exercise.This conversation gives listeners a practical, realistic look at how to support better metabolic health without chasing perfection. If you want a clearer, more balanced understanding of blood sugar imbalances and insulin resistance, you'll get a lot out of this episode.To take the Save My Thyroid Quiz visit www.savemythyroid.com/quiz Free resources for your thyroid healthGet your FREE Thyroid and Immune Health Restoration Action Points Checklist at SaveMyThyroidChecklist.comHigh-Quality Nutritional Supplements For Hyperthyroidism and Hashimoto' s Have you checked out my new ThyroSave supplement line? These high-quality supplements can benefit those with hyperthyroidism and Hashimoto's, and you can receive special offers, along with 10% off your first order, by signing up for emails and text messages when you visit ThyroSave.com. Do You Want Help Saving Your Thyroid?Get free access to hundreds of articles and blog posts: https://www.naturalendocrinesolutions.com/articles/all-other-articles Watch Dr. Eric's YouTube channel: https://www.youtube.com/c/NaturalThyroidDoctor/videos Join Dr. Eric's Graves' disease and Hashimoto's group: https://www.facebook.com/groups/saveyourthyroid Take the Thyroid Saving Score Quiz: https://quiz.savemythyroidquiz.com/sf/237dc308 Read all of Dr. Eric's published books: http://savemythyroid.com/thyroidbooks Work with Dr. Eric: https://savemythyroid.com/work-with-dr-eric/

In this episode, Greg and I covered everything from LASIK stories and gym culture to CGMs and deloads, but the real theme was intentional living. We both did an unplanned digital detox over the weekend — no social media, no constant email checking, no reacting to every notification. And nothing broke. Sales still came in. Emails could wait. What we gained instead was presence — with family, with training, with real life.Phones have become the adult pacifier. Scrolling doesn't solve anxiety, boredom, or stress — it just numbs it. Time is the only non-renewable resource we have. If you're physically present but mentally tethered to your device, you're absent. So I'm doubling down on boundaries: batching emails, no reactive mornings, fewer distractions, more depth. When you remove noise, you amplify what actually matters.We also talked training — a strategic deload using machines to reduce CNS fatigue while keeping intensity high — and my current CGM experiment. Heavy training spikes glucose slightly. OMAD with high fat? Flat line. Data reinforces the philosophy: adequate fat stabilizes the response. And no, I didn't promote high fat to sell Keto Bricks — I built Keto Brick because I needed it first. Which is fitting, because March marks eight years since launch. Eight years of refining, leveling up, and doing the work.Key Takeaways:Digital detox creates clarity and presence.Most “urgent” communication isn't actually urgent.Boundaries protect your time and energy.Strategic deloads can increase long-term performance.High-fat OMAD keeps glucose remarkably stable (for me).Standards matter in natural bodybuilding — pro cards should be earned.Talk is cheap. Execution wins.Next episode we'll be reporting back post–Tough Mudder — cold, muddy, and better for it.Greg Mahler is also a lifetime natural bodybuilder, and can be followed on Instagramhttps://www.instagram.com/ketogreg80/Register For My FREE Masterclass: https://www.ketobodybuilding.com/registration-2Get Keto Brick: https://www.ketobrick.com/Subscribe to the podcast: https://open.spotify.com/show/42cjJssghqD01bdWBxRYEg?si=1XYKmPXmR4eKw2O9gGCEuQ

Kathleen discusses her 24-year journey using Type 1 tools for Type 2 management. She covers Mounjaro success, evolving tech, and why CGMs now beat alert dogs. Free Juicebox Community (non Facebook) Type 1 Diabetes Pro Tips - THE PODCAST Eversense CGM Medtronic Diabetes Tandem Mobi ** Use code JUICEBOX to save 40% at Cozy Earth  CONTOUR NextGen smart meter and CONTOUR DIABETES app Dexcom G7 Go tubeless with Omnipod 5 or Omnipod DASH * Get your supplies from US MED  or call 888-721-1514 Touched By Type 1 Take the T1DExchange survey Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! *The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.  ** t:slim X2 or Tandem Mobi w/ Control-IQ+ technology (7.9 or newer). RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older. BOXED WARNING:Control-IQ+ technology should not be used by people under age 2, or who use less than 5 units of insulin/day, or who weigh less than 20 lbs. Safety info: tandemdiabetes.com/safetyinfo Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!